Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FILANA THERAPEUTICS, INC.SAVA · Entity 7294 | Director | May 16, 2024 | May 16, 2024 |
| Salesforce, Inc.CRM · Entity 2842 | Director | May 22, 2023 | May 23, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FILANA THERAPEUTICS, INC.
Report date May 16, 2024 · Filed May 16, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 950,851 |
Reported balance
After 2024-05-16 transaction · row 1
1 source rowRow 1 · 2024-05-16 · Gift · Disposed 5,000 · Balance 950,851 |
| Common StockSEC Table I · non-derivative | IndirectBy spouse | 5,000 |
Reported balance
After 2024-05-16 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2024-05-16 · Gift · Acquired 5,000 · Balance 5,000 |
| Common StockSEC Table I · non-derivative | IndirectBy family | 180,000 |
Reported balance
Holding disclosure · report date 2024-05-16 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 180,000 |
Salesforce, Inc.
Report date May 22, 2023 · Filed May 23, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,317 |
Reported balance
After 2023-05-22 transaction · row 1
1 source rowRow 1 · 2023-05-22 · Exercise / conversion · Acquired 535 · Balance 30,317 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2023-05-22 | Direct | 0 |
Reported balance
After 2023-05-22 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-05-22 · Exercise / conversion · Disposed 535 · Balance 0 F1: Restricted Stock Units convert to shares of common stock on a one-for-one basis. F2: These restricted stock units vest as to 50% of the original grant on each of February 22, 2023 and May 22, 2023. |
| Common StockSEC Table I · non-derivative | IndirectJeanne Robertson Marital Trust B dtd 2/8/18 | 50,000 |
Reported balance
Holding disclosure · report date 2023-05-22 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 50,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units convert to shares of common stock on a one-for-one basis.
F2: These restricted stock units vest as to 50% of the original grant on each of February 22, 2023 and May 22, 2023.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
RPX Corp
Report date June 19, 2018 · Filed June 19, 2018
Section 16 reporting ended · disclosed 2018-06-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-06-19 transaction · row 1
1 source rowRow 1 · 2018-06-19 · Other · Disposed 244,610 · Balance 0 F1: Issuer entered into an Agreement and Plan of Merger, dated April 30, 2018 (the "Merger Agreement"), by and among the Issuer, Riptide Parent, LLC ("Parent"), and Riptide Purchaser, Inc., a wholly owned subsidiary of Parent ("Purchaser"). Parent and Purchaser are beneficially owned by affiliates of HGGC, LLC. Pursuant to the Merger Agreement and the tender offer commenced in connection therewith, each share of Issuer common stock held by the Reporting Person was tendered for $10.50 per share in cash (the "Offer Price"), without interest and subject to any required withholding of taxes. Pursuant to the Merger Agreement, on June 19, 2018, Purchaser was merged with and into the Issuer (the "Merger"), with the Issuer being the surviving corporation and becoming a wholly owned subsidiary of Parent. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.45 · Expires 2021-05-08 | Direct | 0 |
Reported balance
After 2018-06-19 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-06-19 · Disposition to issuer · Disposed 60,000 · Balance 0 F3: Upon or in connection with the Merger, this option was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the excess, if any, of the Offer Price over the applicable per-share exercise price of such cancelled option, multiplied by (ii) the total number of shares of Issuer's common stock underlying such option, less any required withholding taxes, provided, that, if the per-share exercise price of any such option was equal to or greater than the Offer Price, such option was cancelled for no consideration. F2: The outstanding stock options subject to the grant are fully vested and exercisable. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.25 · Expires 2022-06-18 | Direct | 0 |
Reported balance
After 2018-06-19 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-06-19 · Disposition to issuer · Disposed 7,500 · Balance 0 F3: Upon or in connection with the Merger, this option was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the excess, if any, of the Offer Price over the applicable per-share exercise price of such cancelled option, multiplied by (ii) the total number of shares of Issuer's common stock underlying such option, less any required withholding taxes, provided, that, if the per-share exercise price of any such option was equal to or greater than the Offer Price, such option was cancelled for no consideration. F2: The outstanding stock options subject to the grant are fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Issuer entered into an Agreement and Plan of Merger, dated April 30, 2018 (the "Merger Agreement"), by and among the Issuer, Riptide Parent, LLC ("Parent"), and Riptide Purchaser, Inc., a wholly owned subsidiary of Parent ("Purchaser"). Parent and Purchaser are beneficially owned by affiliates of HGGC, LLC. Pursuant to the Merger Agreement and the tender offer commenced in connection therewith, each share of Issuer common stock held by the Reporting Person was tendered for $10.50 per share in cash (the "Offer Price"), without interest and subject to any required withholding of taxes. Pursuant to the Merger Agreement, on June 19, 2018, Purchaser was merged with and into the Issuer (the "Merger"), with the Issuer being the surviving corporation and becoming a wholly owned subsidiary of Parent.
F2: The outstanding stock options subject to the grant are fully vested and exercisable.
F3: Upon or in connection with the Merger, this option was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the excess, if any, of the Offer Price over the applicable per-share exercise price of such cancelled option, multiplied by (ii) the total number of shares of Issuer's common stock underlying such option, less any required withholding taxes, provided, that, if the per-share exercise price of any such option was equal to or greater than the Offer Price, such option was cancelled for no consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 16, 2024 Filed May 16, 2024 23:13 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-017355 · rdgdoc.xml · nonDerivative · entry 2 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 5,000 Read SEC document |
| May 16, 2024 Filed May 16, 2024 23:13 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-017355 · rdgdoc.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 950,851 Read SEC document |
| May 09, 2024 Filed May 13, 2024 20:15 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $21.11 | $0.00 |
DisclosureSEC source: 0001437749-24-016243 · rdgdoc.xml · derivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2034-05-09 F1 · derivative.exercise_date: Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month. Read SEC document |
| April 26, 2024 Filed Apr 30, 2024 13:13 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | Exercise / conversionCommon Stock Warrant · Derivative | 46,000 | $0.00 Strike: $33.00 | $0.00 |
DisclosureSEC source: 0001437749-24-013866 · rdgdoc.xml · derivative · entry 5 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308,740 Underlying: Common Stock · 69,000 shares Expires 2024-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Form 4 represents exercise of common stock warrants received on January 3, 2024 for cash. Holder received one and one-half shares of common stock for each common stock warrant exercised. Read SEC document |
| April 26, 2024 Filed Apr 30, 2024 13:13 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | Exercise / conversionCommon Stock | 69,000 | $22.00 | $1,518,000.00 |
DisclosureSEC source: 0001437749-24-013866 · rdgdoc.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 955,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Form 4 represents exercise of common stock warrants received on January 3, 2024 for cash. Holder received one and one-half shares of common stock for each common stock warrant exercised. Read SEC document |
| January 03, 2024 Filed Apr 30, 2024 13:13 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | GrantCommon Stock Warrant · Derivative | 354,740 | $0.00 Strike: $33.00 | $0.00 |
DisclosureSEC source: 0001437749-24-013866 · rdgdoc.xml · derivative · entry 4 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 354,740 Underlying: Common Stock · 532,110 shares Expires 2024-05-07 F1 · shares: Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16. Read SEC document |
| January 03, 2024 Filed Apr 30, 2024 13:13 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | GrantCommon Stock Warrant · Derivative | 72,000 | $0.00 Strike: $33.00 | $0.00 |
DisclosureSEC source: 0001437749-24-013866 · rdgdoc.xml · derivative · entry 3 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By family Disclosed balance after: 72,000 Underlying: Common Stock · 108,000 shares Expires 2024-05-07 F1 · shares: Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16. Read SEC document |
| August 23, 2023 Filed Aug 24, 2023 20:06 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | PurchaseCommon Stock | 30,000 | $17.45 | $523,500.00 |
DisclosureSEC source: 0001069530-23-000045 · certent-form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 886,851 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $17.21 to $17.64 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| May 22, 2023 Filed May 23, 2023 20:37 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionRestricted Stock Units · Derivative | 535 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016603 · form4.xml · derivative · entry 3 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 535 shares Expires 2023-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert to shares of common stock on a one-for-one basis. F2 · derivative.exercise_date: These restricted stock units vest as to 50% of the original grant on each of February 22, 2023 and May 22, 2023. Read SEC document |
| May 22, 2023 Filed May 23, 2023 20:37 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionCommon Stock | 535 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016603 · form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2023 Filed May 10, 2023 20:08 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | Exercise / conversionStock Opton (Right to Buy) · Derivative | 2,142 | $16.66 Strike: $16.66 | $35,685.72 |
DisclosureSEC source: 0001069530-23-000033 · certent-form4.xml · derivative · entry 7 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,142 shares Expires 2023-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2023 Filed May 10, 2023 20:08 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | Exercise / conversionStock Opton (Right to Buy) · Derivative | 3,571 | $16.66 Strike: $16.66 | $59,492.86 |
DisclosureSEC source: 0001069530-23-000033 · certent-form4.xml · derivative · entry 6 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,571 shares Expires 2023-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2023 Filed May 10, 2023 20:08 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,571 | $19.60 Strike: $19.60 | $69,991.60 |
DisclosureSEC source: 0001069530-23-000033 · certent-form4.xml · derivative · entry 5 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,571 shares Expires 2023-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2023 Filed May 10, 2023 20:08 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | Exercise / conversionCommon Stock | 2,142 | $16.66 | $35,685.72 |
DisclosureSEC source: 0001069530-23-000033 · certent-form4.xml · nonDerivative · entry 3 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 856,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2023 Filed May 10, 2023 20:08 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | Exercise / conversionCommon Stock | 3,571 | $16.66 | $59,492.86 |
DisclosureSEC source: 0001069530-23-000033 · certent-form4.xml · nonDerivative · entry 2 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 854,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2023 Filed May 10, 2023 20:08 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | Exercise / conversionCommon Stock | 3,571 | $19.60 | $69,991.60 |
DisclosureSEC source: 0001069530-23-000033 · certent-form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 851,138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2023 Filed May 8, 2023 20:13 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | GrantStock Option (Right to Buy) · Derivative | 5,000 | $22.34 Strike: $22.34 | $111,700.00 |
DisclosureSEC source: 0001069530-23-000029 · certent-form4.xml · derivative · entry 2 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2033-05-04 F2 · derivative.exercise_date: Stock options vest over a one (1) year period at a rate of 1/12th per month. Read SEC document |
| May 04, 2023 Filed May 8, 2023 20:13 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $22.34 Strike: $22.34 | $446,800.00 |
DisclosureSEC source: 0001069530-23-000029 · certent-form4.xml · derivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 20,000 shares Expires 2033-05-04 F1 · derivative.exercise_date: Stock options vest over a three (3) year period at a rate of 1/36th per month. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 02:08 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionRestricted Stock Units · Derivative | 535 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006916 · form4.xml · derivative · entry 3 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535 Underlying: Common Stock · 535 shares Expires 2023-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert to shares of common stock on a one-for-one basis. F2 · derivative.exercise_date: These restricted stock units vest as to 50% of the original grant on each of February 22, 2023 and May 22, 2023. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 02:08 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionCommon Stock | 535 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006916 · form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 23:42 UTC | Salesforce, Inc. CRM · Entity 2842 | GrantRestricted Stock Units · Derivative | 1,070 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005948 · form4.xml · derivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,070 Underlying: Common Stock · 1,070 shares Expires 2023-05-22 F1 · derivative.exercise_price: Restricted Stock Units convert to shares of common stock on a one-for-one basis. F2 · derivative.exercise_date: These restricted stock units vest as to 50% of the original grant on each of February 22, 2023 and May 22, 2023. Read SEC document |
| November 22, 2022 Filed Nov 24, 2022 01:09 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionRestricted Stock Units · Derivative | 425 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-026379 · form4.xml · derivative · entry 3 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 425 shares Expires 2022-11-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert to shares of common stock on a one-for-one basis. F2 · derivative.exercise_date: These restricted stock units vest as to 25% of the original grant on each of February 22, 2022, May 22, 2022, August 22, 2022, and November 22, 2022. Read SEC document |
| November 22, 2022 Filed Nov 24, 2022 01:09 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionCommon Stock | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-026379 · form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 20:00 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | Exercise / conversionCommon Stock · Derivative | 2,802 | $23.59 Strike: $23.59 | $66,099.18 |
DisclosureSEC source: 0001069530-22-000043 · certent-form4.xml · derivative · entry 2 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,802 shares Expires 2022-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 20:00 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | Exercise / conversionCommon Stock | 2,802 | $23.59 | $66,099.18 |
DisclosureSEC source: 0001069530-22-000043 · certent-form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,027,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 00:59 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionRestricted Stock Units · Derivative | 425 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-021503 · form4.xml · derivative · entry 3 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 425 shares Expires 2022-11-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert to shares of common stock on a one-for-one basis. F2 · derivative.exercise_date: These restricted stock units vest as to 25% of the original grant on each of February 22, 2022, May 22, 2022, August 22, 2022, and November 22, 2022. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 00:59 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionCommon Stock | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-021503 · form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 20:24 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | PurchaseCommon Stock | 100,000 | $20.69 | $2,069,000.00 |
DisclosureSEC source: 0001069530-22-000035 · certent-form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,024,765 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $19.79 to $21.31 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| June 30, 2022 Filed Jun 30, 2022 21:45 UTC | Salesforce, Inc. CRM · Entity 2842 | GiftCommon Stock | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018303 · form4.xml · nonDerivative · entry 2 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Jeanne Robertson Marital Trust B dtd 2/8/18 Disclosed balance after: 50,000 F1 · kind: Gift of shares to Jeanne Robertson Marital Trust B dtd 2/8/18 by Sanford Robertson. Read SEC document |
| June 30, 2022 Filed Jun 30, 2022 21:45 UTC | Salesforce, Inc. CRM · Entity 2842 | GiftCommon Stock | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018303 · form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,397 F1 · kind: Gift of shares to Jeanne Robertson Marital Trust B dtd 2/8/18 by Sanford Robertson. Read SEC document |
| May 22, 2022 Filed May 24, 2022 22:20 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionRestricted Stock Units · Derivative | 425 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015485 · form4.xml · derivative · entry 4 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850 Underlying: Common Stock · 425 shares Expires 2022-11-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert to shares of common stock on a one-for-one basis. F2 · derivative.exercise_date: These restricted stock units vest as to 25% of the original grant on each of February 22, 2022, May 22, 2022, August 22, 2022, and November 22, 2022. Read SEC document |
| May 22, 2022 Filed May 24, 2022 22:20 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionCommon Stock | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015485 · form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2022 Filed Mar 28, 2022 21:57 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | Exercise / conversionCommon Stock · Derivative | 4,670 | $20.30 Strike: $20.30 | $94,801.00 |
DisclosureSEC source: 0001069530-22-000015 · certent-form4.xml · derivative · entry 2 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,670 shares Expires 2022-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2022 Filed Mar 28, 2022 21:57 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | Exercise / conversionCommon Stock | 4,670 | $20.30 | $94,801.00 |
DisclosureSEC source: 0001069530-22-000015 · certent-form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 924,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 01:16 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionRestricted Stock Units · Derivative | 426 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006399 · form4.xml · derivative · entry 4 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,275 Underlying: Common Stock · 426 shares Expires 2022-11-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert to shares of common stock on a one-for-one basis. F2 · derivative.exercise_date: These restricted stock units vest as to 25% of the original grant on each of February 22, 2022, May 22, 2022, August 22, 2022, and November 22, 2022. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 01:16 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionCommon Stock | 426 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006399 · form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 00:53 UTC | Salesforce, Inc. CRM · Entity 2842 | GrantRestricted Stock Units · Derivative | 1,701 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-003085 · form4.xml · derivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,701 Underlying: Common Stock · 1,701 shares Expires 2022-11-22 F1 · derivative.exercise_price: Restricted Stock Units convert to shares of common stock on a one-for-one basis. F2 · derivative.exercise_date: These restricted stock units vest as to 25% of the original grant on each of February 22, 2022, May 22, 2022, August 22, 2022, and November 22, 2022. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 00:01 UTC | Salesforce, Inc. CRM · Entity 2842 | GiftCommon Stock | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-031626 · form4.xml · nonDerivative · entry 3 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,546 F2 · kind: Gifts to charitable organizations. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 00:01 UTC | Salesforce, Inc. CRM · Entity 2842 | GiftCommon Stock | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-031626 · form4.xml · nonDerivative · entry 2 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,546 F1 · kind: Gift of shares to Sanford Robertson by Jeanne Robertson Marital Trust B dtd 2/8/18. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 00:01 UTC | Salesforce, Inc. CRM · Entity 2842 | GiftCommon Stock | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-031626 · form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Jeanne Robertson Marital Trust B dtd 2/8/18 Disclosed balance after: 39,000 F1 · kind: Gift of shares to Sanford Robertson by Jeanne Robertson Marital Trust B dtd 2/8/18. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:06 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionRestricted Stock Units · Derivative | 410 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-046041 · doc4.xml · derivative · entry 3 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 410 shares Expires 2021-11-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert to shares of common stock on a one-for-one basis. F2 · derivative.exercise_date: These restricted stock units vest as to 25% of the original grant on each of February 22, 2021, May 22, 2021, August 22, 2021, and November 22, 2021. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:06 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionCommon Stock | 410 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-046041 · doc4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2021 Filed Aug 23, 2021 23:45 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionRestricted Stock Units · Derivative | 410 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024189 · form4.xml · derivative · entry 3 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 410 Underlying: Common Stock · 410 shares Expires 2021-11-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert to shares of common stock on a one-for-one basis. F2 · derivative.exercise_date: These restricted stock units vest as to 25% of the original grant on each of February 22, 2021, May 22, 2021, August 22, 2021, and November 22, 2021. Read SEC document |
| August 22, 2021 Filed Aug 23, 2021 23:45 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionCommon Stock | 410 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024189 · form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2021 Filed May 25, 2021 00:47 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionRestricted Stock Units · Derivative | 410 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017932 · form4.xml · derivative · entry 3 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 820 Underlying: Common Stock · 410 shares Expires 2021-11-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert to shares of common stock on a one-for-one basis. F2 · derivative.exercise_date: These restricted stock units vest as to 25% of the original grant on each of February 22, 2021, May 22, 2021, August 22, 2021, and November 22, 2021. Read SEC document |
| May 22, 2021 Filed May 25, 2021 00:47 UTC | Salesforce, Inc. CRM · Entity 2842 | Exercise / conversionCommon Stock | 410 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017932 · form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 01:14 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | Exercise / conversionCommon Stock · Derivative | 4,670 | $49.00 Strike: $49.00 | $228,830.00 |
DisclosureSEC source: 0001069530-21-000024 · certent-form4.xml · derivative · entry 4 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,670 shares Expires 2021-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 01:14 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | Exercise / conversionCommon Stock · Derivative | 2,802 | $27.37 Strike: $27.37 | $76,690.74 |
DisclosureSEC source: 0001069530-21-000024 · certent-form4.xml · derivative · entry 3 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,802 shares Expires 2021-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 01:14 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | Exercise / conversionCommon Stock | 4,670 | $49.00 | $228,830.00 |
DisclosureSEC source: 0001069530-21-000024 · certent-form4.xml · nonDerivative · entry 2 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 920,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 01:14 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | Exercise / conversionCommon Stock | 2,802 | $27.37 | $76,690.74 |
DisclosureSEC source: 0001069530-21-000024 · certent-form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 915,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.